INTERPACE BIOSCIENCES, INC. (IDXG) › Cash & EquivalentsINTERPACE BIOSCIENCES, INC. (IDXG) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2009: $72.46M2010: $62.71M2011: $64.34M2012: $52.78M2013: $45.64M2014: $23.11M2015: $8.31M2016: $602.0K2017: $15.20M2018: $6.07M2019: $2.32M2020: $2.77M2021: $2.67M2022: $4.83M2023: $3.50M2024: $1.46M2025: $2.50M$2.50M2009Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$2.50M+71.5%2024$1.46M-58.2%2023$3.50M-27.5%2022$4.83M+80.7%2021$2.67M-3.6%2020$2.77M+19.4%2019$2.32M-61.8%2018$6.07M-60.1%2017$15.20M+2424.8%2016$602.0K-92.8%2015$8.31M-64.0%2014$23.11M-49.4%2013$45.64M-13.5%2012$52.78M-18.0%2011$64.34M+2.6%2010$62.71M-13.5%2009$72.46M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share